PHOTOCURE ASA v. Dudas
District Court, E.D. Virginia
1Opinion of the Court
MEMORANDUM OPINION
LIAM O’GRADY, District Judge.
In this action, Plaintiff PhotoCure seeks to extend the term of its drug patent, which was effectively shortened by the lengthy Food and Drug Administration (“FDA”) approval process. 35 U.S.C. § 156 (2006) permits patent term extensions in such circumstances, provided that the applicant meets specific statutory elements. One such element requires that the drug be the first permitted commercial marketing or use of “the product.” 35 U.S.C. § 156(a)(5)(A) (2006). On May 13, 2008, the Defendants, employees of the United States Patent and Trademark…
2Cases cited16 opinions
- Chevron U. S. A. Inc. v. Natural Resources Defense Council, Inc.Supreme Court of the United States · 1984
- Skidmore v. Swift & Co.Supreme Court of the United States · 1944
- United States v. Mead Corp.Supreme Court of the United States · 2001
- Camp v. PittsSupreme Court of the United States · 1973
- Christensen v. Harris CountySupreme Court of the United States · 2000
11 more not listed; retrieve them via the Exa API.
3Cited by4 opinions
- PHOTOCURE ASA v. KapposCourt of Appeals for the Federal Circuit · 2010
- Angiotech Pharmaceuticals Inc. v. LeeDistrict Court, E.D. Virginia · 2016
- Biogen International GmbH v. Banner Life Sciences LLCDistrict Court, D. Delaware · 2020
- GENETICS & IVF INSTITUTE v. KapposDistrict Court, E.D. Virginia · 2011